Fifth meeting on use of vaccines for prevention of influenza

expert meeting
18 Feb 2016
ECDC, Stockholm, Sweden
ECDC

​Experts from ECDC will meet representatives from influenza vaccine manufacturers to discuss prevention of influenza in Europe.

Invited representatives from influenza vaccine manufacturers will meet with staff from ECDC to discuss the use of vaccines in the prevention of influenza.

The objective of the meeting is to share the latest information on monitoring of influenza disease and any new developments related to the production of vaccines.

On ECDC’s part, presentations will cover topics including the Burden of Disease project, monitoring and evaluation of the 2009 European Council recommendation on seasonal influence, and ECDC’s vision for monitoring and evaluation of vaccination programmes at the EU/EEA level.

Industry organisation Vaccines Europe will also give a presentation covering the challenges currently being faced by influenza vaccine manufacturers, as well as options for action to overcome these barriers.

Each manufacturer in attendance will also present their current seasonal and pandemic influenza vaccines, as well as any developments currently being worked on.

ECDC influenza updates

Publication

Communicable disease threats report, 17-23 December 2017, week 51

publication -

Publication

Risk assessment for seasonal influenza, EU/EEA, 2017–2018

risk assessment -

Publication

Communicable disease threats report, 10-16 December 2017, week 50

publication -

Publication

Influenza virus characterisation, Summary Europe, November 2017

surveillance report -

Publication

Communicable disease threats report, 3-9 December 2017, week 49

publication -